CVS to Spin Off Retail Pharmacy by 2028, Unwinding Aetna-Caremark Structure
Updated
Updated · The New York Times · Nov 4
CVS to Spin Off Retail Pharmacy by 2028, Unwinding Aetna-Caremark Structure
3 articles · Updated · The New York Times · Nov 4
Summary
CVS Health plans to separate its retail pharmacy business from Aetna and Caremark in a breakup that reports say would rank among the biggest in US healthcare.
The split is expected in the first half of 2028, according to the Wall Street Journal, after the Financial Times first reported the plan citing people familiar with the matter.
That move would reverse CVS's 2018 Aetna acquisition by creating two public companies—one centered on retail pharmacies and the other on insurance and pharmacy benefits management.
CVS has framed the restructuring around improving consumer engagement and affordability while responding to mounting legislative scrutiny of pharmacy benefit managers.
After spending billions to build a healthcare monopoly, why is CVS suddenly tearing it all down by 2028?
Will dismantling a $78 billion healthcare empire actually lower your prescription costs, or just create new bureaucratic nightmares?
CVS Health’s $412 Billion Breakup: Why the Pharmacy Giant Is Splitting in Two and What It Means for Healthcare, Consumers, and Wall Street
Overview
CVS Health, after a strategic review by its board, announced in November 2026 that it will split into two independent companies—CVS Health (insurance, PBM, clinics) and CVS Pharmacy (retail, mail-order, tech)—by 2028. This move unwinds two decades of vertical integration, driven by surging medical costs in Aetna, declining retail margins, regulatory crackdowns on PBMs, and new laws targeting conglomerate ownership. Leadership transitions and workforce restructuring are underway, aiming to restore investor confidence and adapt to changing market and regulatory pressures. The split also preempts potential forced divestitures as federal and state scrutiny intensifies across the industry.